/PRNewswire/ Johnson & Johnson Consumer Inc. will present new research highlighting important advances in the understanding and treatment of skin at the.
Strides Pharma Science announced that its
step-down wholly owned subsidiary, Strides Pharma Global, Singapore, has received
approval for Ibuprofen Oral Suspension USP,100 mg/5 mL (OTC) from the United States Food &
Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the
Reference Listed Drug (RLD), Children s Motrin Oral Suspension, 100 mg/mL, of Johnson & Johnson
Consumer Inc.
Strides is focusing on building a private label business in the US by leveraging its portfolio of products
across soft gels, tablets, capsules, topicals, powders and oral solutions.
Ibuprofen Oral Suspension
USP,100 mg/5 mL (OTC) further strengthens company s private label portfolio for the US market. According to IRi data, the US market for Ibuprofen Oral Suspension USP,100 mg/5 mL (OTC) is